UK's MHRA says semaglutide injection approved to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced liver fibrosis

Newsquawk StaffPublished On the live feed at 2 more headlines followed before this page went public
Newsquawk headlinesUTC

Outgoing Tech Adviser says US President Trump will never back a US AI regulator, reports FT

US says it is monitoring oil markets for price-fixing

UK's MHRA says semaglutide injection approved to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced liver fibrosis

Continental AG (CON GY) confirms that it is in the final stages of concluding an agreement to sell its ContiTech group sector to Lone Star Funds

Newsquawk European Market Wrap - 3rd July 2026

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Related headlines

The whole workspace, free to try.

Try it free